Terms: = Lung cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Treatment
138 results:
1. Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: Cervical lymph node metastasis is an important association factor.
Hua X; Feng W; Ye M; Lai M; Yu X; Sun M; Li J; Ai R; He Y; Cai L; Shi C; Liu X
Cancer Med; 2024 May; 13(9):e7206. PubMed ID: 38686619
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of immune checkpoint inhibitors in SMARCA4-deficient and TP53 mutant undifferentiated lung cancer.
Chen J; Zheng Q; Wang J; Zhang X; Lv Y
Medicine (Baltimore); 2024 Feb; 103(8):e36959. PubMed ID: 38394494
[TBL] [Abstract] [Full Text] [Related]
3. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
4. Primary pulmonary adenoid cystic carcinoma: A clinicopathological study of 64 patients.
Tan X; Xu T; Shen W; Ai C; Zhang W; Tang X; Luo F; Zhou Q
Thorac Cancer; 2024 Feb; 15(5):386-393. PubMed ID: 38148673
[TBL] [Abstract] [Full Text] [Related]
5. Bronchiole adenoma/pulmonary ciliated mucinous nodular papillary tumor: Case series and literature review.
Liu S; Cai X; Pan J; Liu S; Lin J; Yue X
Medicine (Baltimore); 2023 Dec; 102(50):e36559. PubMed ID: 38115282
[TBL] [Abstract] [Full Text] [Related]
6. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
[TBL] [Abstract] [Full Text] [Related]
7. Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with liver metastases.
Qu FJ; Zhou Y; Wu S
Br J Cancer; 2024 Feb; 130(2):165-175. PubMed ID: 37945751
[TBL] [Abstract] [Full Text] [Related]
8. Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis lungs Is Not Resolved by CFTR Modulators.
Wang S; Niroula S; Hoffman A; Khorrami M; Khorrami M; Yuan F; Gasser GN; Choi S; Liu B; Li J; Metersky ML; Vincent M; Crum CP; Boucher RC; Karmouty-Quintana H; Huang HJ; Sheshadri A; Dickey BF; Parekh KR; Engelhardt JF; McKeon FD; Xian W
Am J Respir Crit Care Med; 2023 Nov; 208(9):930-943. PubMed ID: 37695863
[No Abstract] [Full Text] [Related]
9. Pulmonary adenoid cystic carcinoma: molecular characteristics and literature review.
Chen Z; Jiang J; Fan Y; Lu H
Diagn Pathol; 2023 May; 18(1):65. PubMed ID: 37198615
[TBL] [Abstract] [Full Text] [Related]
10. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
11. Organ-specific immune checkpoint inhibitor treatment in lung cancer: a systematic review and meta-analysis.
Yu S; Zhang S; Xu H; Yang G; Xu F; Yang L; Chen D; An G; Wang Y
BMJ Open; 2023 Mar; 13(3):e059457. PubMed ID: 36931679
[TBL] [Abstract] [Full Text] [Related]
12. Identification of THSD7B and PRMT9 mutations as risk factors for familial lung adenocarcinoma: A case report.
Zhang Q; Zhao Y; Song Z; Zhang Q; Tian C; Li R; Zheng J; Yan L; Gu M; Jia X; Li M
Medicine (Baltimore); 2023 Feb; 102(6):e32872. PubMed ID: 36820582
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of clinical features, treatment, and prognosis of primary Xlymphoepithelioma-like carcinoma of the lung.
Hu HY; Long L; Dai SA; Yan GQ; Huang Y; He J
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(24):9416-9425. PubMed ID: 36591850
[TBL] [Abstract] [Full Text] [Related]
14. Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials.
Niu Z; Jin R; Zhang Y; Li H
Signal Transduct Target Ther; 2022 Oct; 7(1):353. PubMed ID: 36198685
[TBL] [Abstract] [Full Text] [Related]
15. Stereotactic Body Radiation Therapy for lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study.
Navarria P; Baldaccini D; Clerici E; Marini B; Cozzi L; Franceschini D; Bertuzzi AF; Quagliuolo V; Torri V; Colombo P; Franzese C; Bellu L; Scorsetti M
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):762-770. PubMed ID: 35987453
[TBL] [Abstract] [Full Text] [Related]
16. PPARgamma agonism inhibits progression of premalignant lesions in a murine lung squamous cell carcinoma model.
Dwyer-Nield LD; McArthur DG; Hudish TM; Hudish LI; Mirita C; Sompel K; Smith AJ; Alavi K; Ghosh M; Merrick DT; Tennis MA; Keith RL
Int J Cancer; 2022 Dec; 151(12):2195-2205. PubMed ID: 35830207
[TBL] [Abstract] [Full Text] [Related]
17. The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer.
Wang Y; Luo N; Gao Y; Wu Y; Qin X; Qi Y; Sun T; Tao R; Qi C; Liu B; Yuan S
J Cancer Res Clin Oncol; 2023 May; 149(5):1679-1690. PubMed ID: 35583828
[TBL] [Abstract] [Full Text] [Related]
18. A Clinical Analysis and Literature Review of Six Cases with Primary Pulmonary Lymphoepithelioma-Like Carcinoma.
Ye L; Luo D; Li H; Zheng H; He S; Lin L; Fang Y; Ye J; Chen C
Comput Math Methods Med; 2022; 2022():1086697. PubMed ID: 35529269
[TBL] [Abstract] [Full Text] [Related]
19. [Clinicopathological and genetic characteristics of bronchial sialadenoma papilliferum: report of four cases].
Liang L; Wu CY; Zhang LP; Hou LK; Dong ZW; Wu W; Lin JL; Huang Y; Xie HK
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):212-217. PubMed ID: 35249284
[No Abstract] [Full Text] [Related]
20. Leptomeningeal Metastases of the Spine: A Systematic Review.
Palmisciano P; Sagoo NS; Kharbat AF; Kenfack YJ; Bin Alamer O; Scalia G; Umana GE; Aoun SG; Haider AS
Anticancer Res; 2022 Feb; 42(2):619-628. PubMed ID: 35093859
[TBL] [Abstract] [Full Text] [Related]
[Next]